R

Researcher Profile

Raquel Izumi

0000-0002-0895-2597

4

Publications

1,240

Citations

10

Co-Authors

4

Active Years

Publications

Journal Article Clinical Cancer Research Jan 18, 2022

First-in-Human Dose-Escalation Study of Cyclin-Dependent Kinase 9 Inhibitor VIP152 in Patients with Advanced Malignancies Shows Early Signs of Clinical Efficacy

Jennifer R. Diamond · Valentina Boni · Emerson Lim · Grzegorz Nowakowski +13 more

10.1158/1078-0432.ccr-21-3617 45 citations

Journal Article Blood Nov 13, 2019

Anti-CD20 Therapy Reliance on Antibody-Dependent Cellular Phagocytosis Affects Combination Drug Choice

Charles C. Chu · Jonathan J. Pinney · Karl R. VanDerMeid · Raquel Izumi +4 more

10.1182/blood-2019-124901 5 citations

Journal Article The Lancet Feb 01, 2018

Acalabrutinib in relapsed or refractory mantle cell lymphoma (ACE-LY-004): a single-arm, multicentre, phase 2 trial

Michael Wang · Simon Rule · Pier Luigi Zinzani · Andre Goy +25 more

10.1016/s0140-6736(17)33108-2 374 citations

Journal Article New England Journal of Medicine Jan 28, 2016

Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic Leukemia

John C. Byrd · Bonnie Harrington · Susan O’Brien · Jeffrey A. Jones +26 more

10.1056/nejmoa1509981 816 citations

Publication Timeline

2022

1

2019

1

2018

1

2016

1

Frequent Co-Authors

Thomas G. Diacovo

Veerendra Munugalavadla

Olivier Casasnovas